FIELD: medicine.
SUBSTANCE: method involves drug therapy and exposure to a physical factor of the bullous changed bladder surface. Exposure covers every point. Every point is exposed to electric current for up to 1.5 sec. The exposure has a frequency of 440 kHz, at a pulse repetition rate of 20-60 kHz, spark coagulation power of 85-95 W at the argon flow of 0.5-0.6 l/min. The therapeutic course is 6-7 procedures every second day.
EFFECT: mucosa exposure involving no adhesive complications or injuries of the mucosa in the form of the secondary tension.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING LEUKOPLAKIA OF URINARY BLADDER | 2006 |
|
RU2310418C1 |
METHOD FOR CHRONIC CYSTITIS TREATMENT | 2016 |
|
RU2626594C1 |
METHOD FOR TREATING THE CASES OF VESICOURETERAL REFLUX | 1998 |
|
RU2148957C1 |
METHOD OF CONSERVATIVE TREATMENT OF BLADDER LEUKOPLAKIA (SQUAMOUS METAPLASIA) | 2008 |
|
RU2390341C2 |
METHOD FOR TREATING THE CASES OF CHRONIC URINARY TRACT INFLAMMATION DISEASE IN CHILDREN | 2001 |
|
RU2199358C2 |
AQUEOUS COMPOSITION FOR INSTILLATION IN BLADDER | 2015 |
|
RU2586285C1 |
METHOD OF DIAGNOSTICS OF BLADDER TUBERCULOSIS | 2006 |
|
RU2341200C2 |
METHOD OF ASSESSING STATE OF MICROCIRCULATION IN FOCUS OF URINARY BLADDER LEUKOPLAKIA IN WOMEN | 2011 |
|
RU2476153C2 |
METHOD FOR TREATING CHILDREN FOR CHRONIC CYSTITIS | 2004 |
|
RU2270678C1 |
METHOD FOR TREATING CHRONIC CYSTITIS IN WOMEN AT CHRONIC INFLAMMATORY DISEASES OF UTERINE ADNEXA | 2005 |
|
RU2294226C1 |
Authors
Dates
2014-08-10—Published
2013-04-09—Filed